Sfoglia per Autore
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells
2023-01-01 Lualdi, Marta; Casale, Federico; Rizzone, Mario Giorgio; Zibetti, Maurizio; Monti, Chiara; Colugnat, Ilaria; Calvo, Andrea; De Marco, Giovanni; Moglia, Cristina; Fuda, Giuseppe; Comi, Cristoforo; Chiò, Adriano; Lopiano, Leonardo; Fasano, Mauro; Alberio, Tiziana
Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: An in vitro study
2021-01-01 Langer T.; Brusatori S.; Carlesso E.; Zadek F.; Brambilla P.; Fusarini C.F.; Duska F.; Caironi P.; Gattinoni L.; Fasano M.; Lualdi M.; Alberio T.; Zanella A.; Pesenti A.; Grasselli G.
Verification of a Parkinson's disease protein signature in T-lymphocytes by multiple reaction monitoring.
2014-01-01 Alberio T; McMahon K; Cuccurullo M; Gethings LA; Lawless C; Zibetti M; Lopiano L; Vissers JP; Fasano M.
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment.
2010-01-01 T. Alberio;M. Colapinto;M. Natale;R. Ravizza;M. B. Gariboldi;E. M. Bucci;L. Lopiano;M. Fasano
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.
2010-01-01 G. Fanali;V. Rampoldi;A. d. Masi;A. Bolli;L. Lopiano;P. Ascenzi;M. Fasano
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.
2010-01-01 T. Alberio;A. M. Bossi;A. Milli;E. Parma;M. B. Gariboldi;G. Tosi;L. Lopiano;M. Fasano
Thermodynamic analysis of hydration in human serum heme-albumin
2009-01-01 Baroni S; Pariani G; Fanali G; Longo D; Ascenzi P; Aime S; Fasano M
Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress
2009-01-01 S. Mila; A. Giuliano Albo; D. Corpillo; S. Giraudo; M. Zibetti; E. M. Bucci; L. Lopiano; M. Fasano
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.
2008-01-01 M. Fasano;T. Alberio;L. Lopiano
Proteomics as a tool to investigate cell models for dopamine toxicity
2008-01-01 M. Fasano; T. Alberio; M. Colapinto; S. Mila; L. Lopiano
Alpha-synuclein and Parkinson's disease: a proteomic view.
2008-01-01 M. Fasano;L. Lopiano
The proteomic approach in Parkinson's disease.
2007-01-01 M. Fasano;B. Bergamasco;L. Lopiano
Expression proteomics of peripheral blood lymphocytes from Parkinson's disease patients
2006-01-01 Mila S; Albo AG; Corpillo D; Zibetti M; Bergamasco B ; Lopiano L ; Fasano M.
Proteomic analysis of dopamine and copper toxicity in SH-SY5Y human neuroblastoma cells expressing alpha-synuclein
2006-01-01 Fasano M; Colapinto M; Mila S; Corpillo D; Bergamasco BB ; Lopiano L.
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease.
2003-01-01 BASSO M ;GIRAUDO S ;LOPIANO L ;BERGAMASCO B ;BOSTICCO E ;CINQUEPALMI A ;FASANO M
Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein.
2003-01-01 FASANO M ;GIRAUDO S ;COHA S ;BERGAMASCO B ;LOPIANO L
Modulation of the antioxidant activity of HO center dot scavengers by albumin binding: a F-19-NMR study
2003-01-01 S. AIME; DIGILIO G.; BRUNO E.; MAINERO V.; BARONI S.; FASANO M.
Magnetic investigations of human mesencephalic neuromelanin
2002-01-01 BOLZONI F; GIRAUDO S; L. LOPIANO; BERGAMASCO B; FASANO M; CRIPPA PR
Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin
2002-01-01 Monzani E; Curto M; Galliano M; Minchiotti L; Aime S; Baroni S; Fasano M; Amoresano A; Salzano AM; Pucci P; Casella L
RELAXOMETRIC CHARACTERIZATION OF HUMAN HEMALBUMIN
2001-01-01 S. AIME; FASANO M.; BARONI S.; VANNINI A.; ASCENZI P.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile